Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The combination therapy was effective and well-tolerated, especially in young patients.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Early diagnosis and treatment of nail lichen planus in children can prevent permanent nail damage.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Effective treatments for severe alopecia areata are still lacking.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

More research is needed to find the best long-term treatments for Alopecia Areata.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.